Saturday, July 11, 2026

pharma · Decompensated Cirrhosis · Primary Ovarian Insufficiency

Shanghai Institute of

Shanghai Institute of clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
114 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
114
Programs
2
Drugs
4
Patents
0
Intelligence · Clinical Programs

Shanghai Institute of projects

2 ClinicalTrials.gov programs sponsored by Shanghai Institute of.

Shanghai Institute of has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Conventional therapy

    Chinese Academy of Sciences

    Decompensated Cirrhosis

    phase 2 mab active

    1 trial
  2. Placebo transplantation

    Chinese Academy of Sciences

    Primary Ovarian Insufficiency

    phase 2 mab active

    1 trial

Frequently asked questions

How many clinical projects does Shanghai Institute of have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.